Temsirolimus: a long-lived antineoplastic drug

Temsirolimus was developed by Hara Wyeth Pharmaceuticals and was approved for listing by FDA in May 2007 for the treatment of renal cell carcinoma. The drug is the first antineoplastic […]
Read More →Temsirolimus was developed by Hara Wyeth Pharmaceuticals and was approved for listing by FDA in May 2007 for the treatment of renal cell carcinoma. The drug is the first antineoplastic […]
Read More →Triple negative breast adenocarcinoma (triple negative breast cancer (TNBC) is a breast cancer with negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2). With unique […]
Read More →According to a new study compounds responsible for heat dissipation in chili peppers may help slow the spread of lung cancer, the leading cause of cancer death in men and […]
Read More →An estimated 4.2 million children worldwide suffer from a peanut allergy. For these patients, even the slightest peanut ingredients can have fatal consequences. Allergic reaction is essentially the binding of allergens […]
Read More →We all know that stress affects many aspects of the body’s health, so what new findings do scientists have? Mol Bio Cell: environmental pressure-mediated gene mutation leads to drug resistance […]
Read More →